References
Groot VP, Rezaee N, Wu W, et al. Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg. 2018;267:936–45.
Maggino L, Malleo G, Crippa S, et al. Ca 19.9 response and tumor size predict recurrence following post-neoadjuvant pancreatectomy in initially resectable and borderline resectable pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12622-w.
Yin L, Pu N, Thompson ED, et al. Improved assessment of response status in patients with pancreatic cancer treated with neoadjuvant therapy using somatic mutations and liquid biopsy analysis. Clin Cancer Res. 2020;27:740–8.
Khalvati F, Zhang Y, Baig S, et al. Prognostic value of CT radiomic features in resectable pancreatic ductal adenocarcinoma. Sci Rep. 2019;9:5449.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
The authors declare no conflict of interest. This paper did not receive financial support.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Maggino, L., Malleo, G., Crippa, S. et al. ASO Author Reflections: Recurrence Following Post-neoadjuvant Pancreatectomy: How Can We Do Better?. Ann Surg Oncol 30, 220–221 (2023). https://doi.org/10.1245/s10434-022-12676-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12676-w